ARCHIVES

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Two Major Appointments Made At Fox Chase; HHS Names Task Force to Look At DRG Research Impact

April 20, 1984

Radiology Program Has Accredited 1,200 Facilities

May 18, 1990

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978

U-Miami Center Gets $27.5 Million Gift for Cancer Programs

October 31, 1986

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011